![uploads///Defitelio](https://media.marketrealist.com/brand-img/Dah7ns0jC/640x335/uploads/2017/09/Defitelio.png 640w)
How Is Jazz’s Defitelio Positioned after 2Q17?
In 2Q17, Jazz Pharmaceuticals’ (JAZZ) Defitelio generated revenues of ~$30 million, which represents a ~10% fall YoY and a ~17% fall QoQ.
The latest news in the healthcare sector including biotech and telehealth.